Tissue Specificity | Highly expressed in liver, skeletal muscle, and kidney. Expressed in cardiomyocytes. Expression is highly reduced in cardiac tissue of patients with non-ischemic cardiomyopathy and aortic aneurysm, and in glomerular disease. Not expressed in bone marrow or lymphoid tissues. |
Function | Transcriptional regulator that binds to the GA element of the CLCNKA promoter. Binds to the KCNIP2 promoter and regulates KCNIP2 circadian expression in the heart. Is a repressor of CCN2 expression, involved in the control of cardiac fibrosis. It is also involved in the control of cardiac hypertrophy acting through the inhibition of MEF2A and GATA4. Involved in podocyte differentiation. Inhibits MYOCD activity. Is a negative regulator of TP53 acetylation. Inhibits NF-kappa-B activation through repression of EP300-dependent RELA acetylation. |
Protein Name | Krueppel-Like Factor 15Kidney-Enriched Krueppel-Like Factor |
Database Links | Reactome: R-HSA-1368108 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Krueppel-Like Factor 15 antibodyAnti-Kidney-Enriched Krueppel-Like Factor antibodyAnti-KLF15 antibodyAnti-KKLF antibody |
Information sourced from Uniprot.org